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Abstract
Background: We analyzed the Genetic Analysis Workshop 13 (GAW13) simulated data to
contrast and compare different methods for the genetic linkage analysis of hypertension and change
in blood pressure over time. We also examined methods for incorporating covariates into the
linkage analysis. We used methods for quantitative trait loci (QTL) linkage analysis with and without
covariates and affected sib-pair (ASP) analysis of hypertension followed by ordered subset analysis
(OSA), using variables associated with change in blood pressure over time.
Results: Four of the five baseline genes and one of the three slope genes were not detected by
any method using conventional criteria. OSA detected baseline gene b35 on chromosome 13 when
using the slope in blood pressure to adjust for change over time. Slope gene s10 was detected by
the ASP analysis and slope gene s11 was detected by QTL linkage analysis as well as by OSA
analysis. Analysis of null chromosomes, i.e., chromosomes without genes, did not reveal significant
increases in type I error. However, there were a number of genes indirectly related to blood
pressure detected by a variety of methods.
Conclusions: We noted that there is no obvious first choice of analysis software for analyzing a
complicated model, such as the one underlying the GAW13 simulated data. Inclusion of covariates
and longitudinal data can improve localization of genes for complex traits but it is not always clear
how best to do this. It remains a worthwhile task to apply several different approaches since one
method is not always the best.
Background
In our analysis of the Genetic Analysis Workshop 13
(GAW13) simulated data for Replicate 1 with no missing
data we had two goals: 1) use the longitudinal informa-
tion to improve our linkage analysis and 2) incorporate
covariates in our linkage analysis. At present, there are no
standard tools for linkage analysis of longitudinal data. In
addition, the incorporation of covariates in linkage
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analysis is a very active area of current methodological
development. As a result there was no "industry standard"
analysis for either of our goals. Consequently, we
explored several approaches to detect the simulated genes.
We opened the answers at the beginning and used the
answers extensively to evaluate our approach.
We investigated different approaches for handling data
from repeated measurements, in this case multiple pheno-
type values collected at different time points. We used
subject-specific slope values to represent change in systo-
lic blood pressure (SBP) over time and considered the
effects of adjusting slopes for potentially important cov-
ariates before the linkage analysis. We used these slopes
directly as traits in quantitative analysis, and as covariates
in linkage analysis of the hypertension as a binary affec-
tion status variable. We chose change over time in SBP as
the quantitative trait for SOLAR multipoint linkage analy-
sis, and used the presence of hypertension (HBP) to
define a binary affection status for affected sib-pair (ASP)
multipoint linkage analysis with SIBLINK [2]. A recently
developed program for ordered subset analysis (OSA) [3]
was used in conjunction with SIBLINK to examine
whether phenotypically homogeneous subgroups of fam-
ilies, based on family-specific mean levels of the slope
covariates, gave improved linkage signals for the underly-
ing simulated SBP quantitative trait loci (QTL), particu-
larly those involved in determining the rate of change in
BP over time.
A key issue in our investigation involved determining
which covariates to use and at what point in our analyses
to adjust for them. We were interested in examining how
inclusion of all covariates in a general model and subse-
quent covariate elimination using a variance-component
analysis method, SOLAR, compared with analysis with
one covariate at a time using a method like OSA, in con-
junction with ASP linkage analysis. A related question was
whether covariates should be included at a family or indi-
vidual level. With OSA, the mean covariate values are
taken over all time points for each individual and then
averaged at the family level. We examined how this
approach might differ from the inclusion of individual
means for all covariates in a mixed model using a vari-
ance-components approach.
We used only one replicate in our analysis. Our initial
goals were implementation of the analysis plan and a lim-
ited consideration of whether our analysis methods could
detect any of the genes involved in change in blood pres-
sure over time. An analysis of all replicates and further
simulation studies are required to begin to make state-
ments about the general performance of covariate-
adjusted linkage methods.
Methods
We used the GAW13 simulated complete data set for Rep-
licate 1 consisting of 2860 genotyped individuals in 330
families. The data set was examined using three genetic
analysis programs: SIBLINK [2], Ordered Subset Analysis
(OSA) [3], and Sequential Oligogenic Linkage Analysis
Routines (SOLAR) [1]. We chose to analyze chromosomes
5, 7, 13, 15, and 21 because they contained genes that
determine blood pressure, acting either at baseline or in
change over time. We analyzed four null chromosomes
(2, 4, 6, 10) to get a sense of the number of type I errors
using OSA based on the mean covariate values in affected/
unaffected individuals. We found that the false positive
rate was consistent with the nominal significance level
(data not shown).
Subject-specific slopes reflecting individual change over
time of SBP were computed with SAS-PROC MIXED [4]
using three different models: unadjusted slope, adjusted
slope, and the "true" slope. The unadjusted slopes fit a
line to the observed longitudinal BP values. The adjusted
slopes fit a model including individual environmental
variables that we considered important in the absence of
knowledge about the true simulation model. Fixed effects
were fit for age, gender, smoking, drinking, and cohort,
and both fixed and random effects were fit for hyperten-
sion treatment. We also computed slope values that were
as close as possible to the "true" values by using the sim-
ulating model for SBP provided in the GAW13 answers,
including the correct transformations of the involved var-
iables. To account for the different number of time points
contributing to the slope estimates for each subject, we
calculated normalized slope values (slope divided by
standard deviation of the estimate).
Variance components analysis (SOLAR) was used to per-
form multipoint linkage analysis using the normalized
individual slope values for SBP (unadjusted, adjusted, and
true) as the quantitative trait values. All families were
included in this analysis. A common constant was added
to make all estimated slope values positive, then the data
were log-transformed and outliers were eliminated to
approximate a normal trait distribution. Heritability was
estimated from the best-fitting polygenic model, starting
with a model that included age (at onset of HBP for
affected individuals, at exam for unaffecteds) and average
values (over all time points) of cholesterol, glucose, HDL,
triglycerides, height, weight, and body mass index (BMI).
Once this model was generated, multipoint linkage anal-
ysis using a variance components approach was carried
out using SOLAR.
SIBLINK v. 3.0 was used to perform multipoint ASP link-
age analysis using HBP as indicated in the data set as a
dichotomous disease trait. There were 171 families with atBMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S50
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least one ASP included in our SIBLINK analysis, for a total
of 575 ASPs with hypertension. SIBLINK was used to cal-
culate family-specific multipoint LOD scores across each
chromosome, based on estimated identity by descent
(IBD) status among affected sibling pairs. The OSA pro-
gram then utilized the multipoint LOD scores and covari-
ate values from each family, attempting to identify
homogeneous subsets of families presenting increased
evidence for linkage. In theory, examining the data from a
homogeneous subset of linked families yields a more
accurate estimate of disease gene location because the
location estimate is not influenced by unlinked families.
The OSA program takes as input, any multipoint set of
additive, family-specific linkage scores, such as LOD
scores from SIBLINK or nonparametric LOD scores from
GENEHUNTER Plus (Kong and Cox). The OSA program
ranked families by mean values of the covariates: the cal-
culated slope values for SBP and additional covariates age
(age at onset of HBP for affected individuals, age at exam
for unaffecteds), cholesterol, glucose, HDL, triglycerides,
height, weight, and BMI. Family-specific means were cal-
culated i) for all affected individuals and ii) for all family
members regardless of affection status (individual values
were averages over all time points). Using one covariate at
a time, family-specific multipoint LOD scores were added
in the covariate-based rank order and the maximum LOD
score for any subset of families was determined for that
covariate. The significance of the increase in the subset-
based LOD score over the global LOD score from all fam-
ilies was assessed with an empirical p-value based on ran-
domly permuting the order in which families were added.
Results
The linkage results for slope variables compared with the
known locations of simulated SBP genes for chromo-
somes 5, 7, 13, 15, and 21 are shown in Table 1 (SOLAR
results) and Table 2 (ASP linkage and OSA results).
Results are presented for OSA using family-specific means
for affected individuals as well as family-specific means
including all individuals in the family. We found no con-
sistent improvement in the linkage signal when using the
mean of all pedigree members compared with the mean
of affected members only, however there could be consid-
erable differences when using the two sets of means.
Tables 1 and 2 also show the results when using the nor-
malized slopes and for the non-normalized slopes. In
most cases the non-normalized results gave stronger
results.
Using standard criteria for identifying regions of interest
(SOLAR LOD > 1.5, ASP LOD > 1.0, or OSA p-value <
0.05), we did not observe any linkage signals within 20
cM of any baseline SBP genes on chromosomes 5, 7, or 13
with ASP combined with ordered subsets analyses (SIB-
LINK/OSA) using the mean of normalized slope values
for all family members or using variance component anal-
ysis on the calculated normalized SBP slope values. OSA
was able to identify gene s11 on chromosome 15 (LOD
2.81 at position 5.1 cM, using mean of unadjusted slope
over affected family members only). Not surprisingly,
since s10 exerts a relatively strong effect on the variance of
SBP over time, our methods were most successful at iden-
tifying slope gene s10 on chromosome 21 (Figure 1).
Analysis of the dichotomized trait (HBP) with SIBLINK
led to the detection of s10 on chromosome 21 (LOD 2.03
at position 56 cM). OSA did not provide a significant
improvement of this score. We also found significant
results with variance component analysis (SOLAR) using
the adjusted SBP slope and the true slope values, both of
which localized within 4 cM of s10 at 54 cM on chromo-
some 21. Aside from this result, SOLAR did not detect any
other slope genes despite the fact that estimated heritabil-
Table 1: Linkage detection on 5 chromosomes with SBP genes using SOLAR QTL variance components linkage analysis.A
Analysis Chr 5 Chr 7 Chr 13 Chr 15 Chr 21
NormB SBP slope (H2 
= 0.18)
0.50 (140) 0.75 (102) 0.20 (70) 0.66 (15) 1.0 (56)
Norm adjusted SBP 
slope (H2 = 0.28)
0.29 (190) 1.72 (97) 0.62 (91) 0.47 (0) 4.2 (51)
Norm "true" SBP 
slope (H2 = 0.24)
0.40 (140) 0.74 (32) 0.54 (44) 0.89 (15) 0.96 (50)
SBP slope (H2 = 0.29) 0.70 (142) 2.17 (125) 0.53 (91) 1.49 (16) 0.32 (55)
Adj SBP slope (H2 = 
0.44)
0.42 (55) 2.20(121) 0.52 (119) 1.59 (5) 6.8 (46)
"True" SBP slope (H2 
= 0.34)
0.64 (141) 1.36 (31) 1.29 (44) 1.13 (15) 0.61 (51)
True location of SBP 
genes (cM)
B34 (176) B36 (47) B35 (85) S11 (4.5) S12 (29) S10 (54)
AValues in the table are the maximum LOD score and the location in cM. BNorm, normalized.BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S50
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ities were significant (normalized slope H2 = 18.10%; nor-
malized adjusted slope H2 = 28.4%; normalized true slope
H2 = 24%). Interestingly, non-normalized slope values
used in SOLAR tended to have higher heritability esti-
mates than normalized slopes (slope H2  = 29.7%;
adjusted slope H2 = 44.5%; true slope H2 = 34.20%),
although the increase in the heritabilities did not auto-
matically lead to larger LOD scores. The analysis of non-
normalized adjusted slope (H2 = 44.5%) found s11 on
chromosome 15 with LOD = 1.59 and s10 on chromo-
some 21 with LOD = 6.80. We analyzed Replicate 7 of the
simulated data and confirmed that the non-normalized
values do appear to give stronger results than the normal-
ized values in that replicate as well.
We also observed linkage signals in regions that did not
harbor SBP genes. On chromosome 7 both the ordered-
subset analysis and the variance-component analysis
detected gene b10 (at position 124 cM, chromosome 7).
In addition, ordered subset analysis detected b3 (at posi-
tion 120 cM on chromosome 13, Figure 2). Both genes
influence SBP indirectly through their influence on
height. However, finding a direct connection between
these genes, hypertension, SBP slope, and height was
difficult.
Conclusions
We noted that there is no obvious first choice of software
for longitudinal data and incorporating covariates for ana-
lyzing such a complicated model as the one underlying
the GAW13 simulated Replicate 1 data set. Having the
answers allowed us to set up analyses to get the best pos-
sible results. However, even with the answers, the results
obtained with adjustment for the true model were not
superior to adjustment for generally accepted covariates.
QTL analysis using the SOLAR program had difficulty
finding the true slope genes, even when the simulating
model was used to calculate individual-specific slopes.
Perhaps our mixed model did not capture the longitudi-
nal aspect of these data as well as we had hoped. We real-
ize that our approach to the longitudinal aspect of the
data was rather ad hoc, stemming from the lack of longi-
tudinal QTL software. Perhaps the slope variables we uti-
lized in our analyses were not optimal. Weighting the
likelihood contributions by the precision of the slope esti-
mates could possibly have improved our analysis.
However, the normalization procedure we used seemed to
reduce the evidence for linkage in some cases, suggesting
that perhaps we were removing some of the genetic varia-
bility when we normalized the slope values. As expected,
we found that dichotomizing and performing ASP analy-
sis (i.e., analyzing only the extreme tail of the distribu-
tion) can lead to successful localization if the QTL is bi-
allelic, has a relatively strong effect on the mean of the dis-
tribution, and if the genotype-specific means are close to
an additive model, which is assumed in ASP analysis
using SIBLINK. Incidentally, this was also the situation
where variance component analysis using SOLAR per-
formed best (chromosome 21).
Table 2: Linkage detection on 5 chromosomes with SBP genes using ASP linkage analysis and OSA.A
Analysis Chr 5 Chr 7 Chr 13 Chr 15 Chr 21
SIBLINK ASP on HBP OSA 0.52 (63) 0.16 (199) 0.0 (--) 0.92 (109) 2.03 (56)
NormB SBP slope (affecteds only) 1.87 (58) p = 0.45 p = 0.003 0.88 (28) p = 0.04 2.81 (5) p = 0.04 3.28 (63) p = 0.16
Norm SBP slope (all individuals) 1.99 (39) p = 0.27 3.13 (124) p = 0.01 2.14(117) p = 0.04 3.61 (99) p = 0.009 2.10 (56) p = 0.80
SBP slope (affecteds only) 2.24(127) p = 0.17 p = 0.12 3.88 (91) p = 0.005 2.53 (105) p = 0.094 2.57 (53) p = 0.58
SBP slope (all individuals) 2.12(112) p = 0.27 2.91 (12) p = 0.03 3.29 (91) p = 0.01 2.36 (106) p = 0.13 2.91 (57) p = 0.38
Norm adjusted SBP slope 
(affecteds only)
1.25(63) p = 0.66 2.07 (140) p = 0.13 1.01 (43) p = 0.44 1.87 (109) p = 0.23 2.37 (53) p = 0.62
Norm adjusted SBP slope (all 
individuals)
1.84(214) p = 0.39 2.50 (107) p = 0.05 3.23(118) p = 0.02 2.11 (99) p = 0.14 2.75 (53) p = 0.44
Adjusted SBP slope (affecteds 
only)
2.41(112) p = 0.17 1.16 (123) p = 0.58 3.69 (91) p = 0.009 1.74 (108) p = 0.38 2.88 (55) p = 0.27
Adjusted SBP slope (all 
individuals)
2.12(112) p = 0.29 2.08 (99) p = 0.05 3.01(122) p = 0.05 1.97 (107) p = 0.19 2.91 (53) p = 0.32
Norm "true" SBP slope (affecteds 
only)
1.34 (61) p = 0.74 2.08 (123) p = 0.15 0.94 (91) p = 0.41 1.96 (108) p = 0.23 2.92 (62) p = 0.45
Norm "true" SBP slope (all 
individuals)
2.14(214) p = 0.25 2.44 (124) p = 0.06 2.54(117) p = 0.05 2.20 (106) p = 0.14 2.72(52) p = 0.44
"True" SBP slope (affecteds only) 2.12(112) p = 0.19 1.95 (37) p = 0.16 4.26 (91) p = 0.002 1.95 (108) p = 0.23 2.92 (55) p = 0.34
"True" SBP slope (all individuals) 2.16(209) p = 0.24 2.37 (99) p = 0.07 3.56 (91) p = 0.009 1.89 (108) p = 0.24 3.15 (58) p = 0.17
True location of SBP genes (cM) B34 (176) B36 (47) B35 (85) S11 (4.5) S12 (29) S10 (54)
AValues in the table are the maximum LOD score and the location in cM. BNorm, normalized.BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S50
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OSA appears to be useful in localization of complex trait
genes, but it can also produce peaks for genes indirectly
related to the trait of interest, particularly when there are
multiple genes on the same chromosome that are corre-
lated with the analyzed trait in a complex way. It is possi-
ble that our detection of the height genes is due to high
heritability of height or strong correlations with other var-
iables. The answers reveal that height is indirectly related
to SBP through its direct contributions to other variables.
When concentrating on a single maximum for the gene
location, we did not detect any baseline genes for SBP
with our approach. However, when there is more than
one gene on a chromosome, localization of any single
gene may be more difficult. For example, on chromosome
13, a high LOD score of 3.2 obtained from OSA occurs
around 118 cM (near the height gene b3 at 120 cM), and
33 cM away from the SBP baseline gene b35 at 85 cM. The
p-values for the increase in the OSA LOD scores in this
region are below 0.05. We also analyzed simulated Repli-
cate 7 to see if any of the patterns observed in Replicate 1
were observed in another replicate. Qualitatively the
localization results were similar in that other genes were
detected, however, we did not observe the same genes as
those in Replicate 1.
There is considerable methodological work to be done to
provide insight into how proximity of other genes may
influence detection and localization of any individual
LOD score curves for linkage results on chromosome 21 Figure 1
LOD score curves for linkage results on chromosome 21. The x-axis is in cM along with the location of genes on that 
chromosome. SOLAR curves are for the normalized SBP slopes. The SIBLINK curve shows the ASP LOD score for HBP.
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gene. We were pleasantly surprised that we were able to
obtain results for any of the baseline genes, since our anal-
ysis was weighted toward detecting slope genes. The OSA
results for chromosome 13 (Figure 2) suggest that in the
ASP analysis of HBP, accounting for BP change over time,
may have uncovered a subset of families segregating base-
line genes that were not detectable because of the variabil-
ity over time. Finally, we found that, even with the
answers, it is difficult to determine which covariates to use
and at what stage we should adjust for these covariates
that are contributing to the phenotype of interest. It is not
clear that using a multivariate regression model with
SOLAR is preferable to examination of covariates one-at-
a-time at the modeling stage for the phenotype using OSA.
It is difficult to make clear recommendations since neither
software package produced consistent results pointing to
the localization of SBP genes, although OSA found s11 on
chromosome 15 and variance components analysis using
SOLAR and ASP analysis using SIBLINK found s10 on
chromosome 21. We focused our investigation on Repli-
cate 1 of the simulated data. Clearly, extending our analy-
ses to include all of the simulation replicates might shed
more light on which methods perform better, and in
which situations.
We are able to conclude from our analyses that inclusion
of covariates and longitudinal data can improve localiza-
tion of genes for complex traits but it is not always clear
LOD score curves for linkage results on chromosome 13 Figure 2
LOD score curves for linkage results on chromosome 13. The x-axis is in cM along with the location of genes on that 
chromosome. SOLAR curves are for the normalized SBP slopes. The SIBLINK curve shows the ASP LOD score for HBP.
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how best to do this. The information used by each
method is slightly different and thus it is not at all surpris-
ing that the different methods pick up different genes in
this complex system. Thus we conclude that it remains a
worthwhile task to apply several different approaches
since one method is not always the best.
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